» Articles » PMID: 17389748

The Macrophage Migration Inhibitory Factor-glucocorticoid Dyad: Regulation of Inflammation and Immunity

Overview
Journal Mol Endocrinol
Date 2007 Mar 29
PMID 17389748
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

The cytokine macrophage migration inhibitory factor (MIF) occupies a unique position in physiology by its ability to directly regulate the immunosuppressive actions of glucocorticoids. We review herein the interactions between MIF and glucocorticoids within the immune system and discuss the relevance of the MIF-glucocorticoid regulatory dyad in physiology and immunopathology. Therapeutic antagonism of MIF may be an effective approach for steroid-sparing therapies in patients with refractory autoimmune or inflammatory diseases.

Citing Articles

Identification of a DNA methylation signature in whole blood of newborn guinea pigs and human neonates following antenatal betamethasone exposure.

Kim B, Kostaki A, McClymont S, Matthews S Transl Psychiatry. 2024; 14(1):465.

PMID: 39511158 PMC: 11543945. DOI: 10.1038/s41398-024-03175-5.


Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis.

Ferhat M, Mayer J, Costa L, Prendecki M, Tarazona A, Schinagl A PLoS One. 2024; 19(10):e0311837.

PMID: 39374239 PMC: 11458038. DOI: 10.1371/journal.pone.0311837.


Analysis of the role of macrophage migration inhibitory factors in host-parasite interactions.

Karabowicz J, Dlugosz E, Baska P, Pekacz M, Wysmolek M, Klockiewicz M J Vet Res. 2024; 68(3):381-388.

PMID: 39318519 PMC: 11418385. DOI: 10.2478/jvetres-2024-0038.


Therapeutic Opportunities in Breast Cancer by Targeting Macrophage Migration Inhibitory Factor as a Pleiotropic Cytokine.

Khezrian A, Shojaeian A, Boroujeni A, Amini R Breast Cancer (Auckl). 2024; 18:11782234241276310.

PMID: 39246383 PMC: 11380135. DOI: 10.1177/11782234241276310.


Longitudinal cytokine and multi-modal health data of an extremely severe ME/CFS patient with HSD reveals insights into immunopathology, and disease severity.

Jahanbani F, Sing J, Maynard R, Jahanbani S, Dafoe J, Dafoe W Front Immunol. 2024; 15:1369295.

PMID: 38650940 PMC: 11033372. DOI: 10.3389/fimmu.2024.1369295.